Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Biliary Tract Neoplasms 3 Nevi and Melanomas 2 Neoplastic Cells, Circulating 2 Neoplasm, Residual 2 Melanoma 2 Lung Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Recurrence 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1

Interventions

Cyclophosphamide 23 venetoclax 17 Dexamethasone 16 pembrolizumab 15 fludarabine 15 Cytarabine 13 pomalidomide 8 Rituximab 8 Gemcitabine 8 Carboplatin 8 Azacitidine 8 glofitamab 7 fludarabine phosphate 7 Lenalidomide 7 selinexor 6 Paclitaxel 6 Injections 6 Immunotherapy, Adoptive 6 Granulocyte Colony-Stimulating Factor 6 Cisplatin 6 daratumumab 5 Temozolomide 5 Bevacizumab 5 zanubrutinib 4 ruxolitinib 4 Surgical Procedures, Operative 4 Oxaliplatin 4 Nivolumab 4 Drug Therapy 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Liquid Biopsy × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡